ALB
NYSE · Chemicals
Albemarle Corp
$116.80
+3.88 (+3.44%)
Financial Highlights (FY 2026)
Revenue
5.18B
Net Income
-514,022,733
Gross Margin
13.1%
Profit Margin
-9.9%
Rev Growth
-11.1%
D/E Ratio
0.34
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 13.1% | 13.1% | 38.2% | 38.2% |
| Operating Margin | -7.6% | -6.8% | 19.2% | 18.7% |
| Profit Margin | -9.9% | -9.4% | 12.9% | 14.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.18B | 5.82B | 6.60B | 5.82B |
| Gross Profit | 678.18M | 762.86M | 2.52B | 2.23B |
| Operating Income | -393,446,979 | -398,315,276 | 1.27B | 1.09B |
| Net Income | -514,022,733 | -520,382,969 | 847.75M | 834.74M |
| Gross Margin | 13.1% | 13.1% | 38.2% | 38.2% |
| Operating Margin | -7.6% | -6.8% | 19.2% | 18.7% |
| Profit Margin | -9.9% | -9.4% | 12.9% | 14.3% |
| Rev Growth | -11.1% | -11.1% | +5.0% | +9.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.65B | 1.65B | 2.54B | 2.67B |
| Total Equity | 4.92B | 4.92B | 6.30B | 6.09B |
| D/E Ratio | 0.34 | 0.34 | 0.40 | 0.44 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 269.36M | 287.84M | 1.64B | 1.66B |
| Free Cash Flow | — | — | 929.19M | 1.04B |